FDA OKs treatment for bacterial vaginosis

Drug Store News, Sept 27, 1999

The FDA has approved Pharmacia & Upjohn's antibiotic Cleocin (clindamycin phosphate) Vaginal Ovules for the three-day treatment of bacterial vaginosis in non-pregnant women.

Administered once-daily, Cleocin Vaginal Ovules are formulated as vaginal suppositories.

Cleocin Vaginal Ovules are contraindicated in women allergic to clindamycin, lincomycin or to the suppository base, and in patients with a history of regional enteritis, ulcerative colitis or "antibiotic-associated" colitis. The safety and efficacy of the product has not been studied in pregnant women.